2022. Analysis of the effectiveness of the combination of bevacizumab and irinotecan for the treatment of glial tumors. Research, Society and Development. 11, 1 (Jan. 2022), e37911125135. DOI:https://doi.org/10.33448/rsd-v11i1.25135.